The Impact of Rapid Diagnostic Methods in the Diagnosis of Fungal Infections in Intensive Care Units of Assiut University Hospital
NCT05876962 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-01-30
Summary
The diagnosis of invasive fungal disease remains challenging in the clinical laboratory. The use of matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) for the identification of filamentous fungi as well as its application for antifungal resistance testing and strain typing Will be evaluated.
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
asmaa omar · professor
-
mohamed zakaria · professor
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-31
- Primary Completion
- 2024-05-31
- Completion
- 2024-12-31
More Related Trials
-
Biofilm Formation and Antifungal Resistance in Candida Species
NCT07245563 ·Status: NOT_YET_RECRUITING
-
Efflux Pump Mediated Azole Resistance in Candida Albicans
NCT03659162 ·Status: UNKNOWN
-
Fungal Infections in Patients With Hematological Malignancies
NCT03650439 ·Status: UNKNOWN
-
Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis
NCT00923832 ·Status: COMPLETED
-
Early Diagnosis of Invasive Lung Aspergillosis
NCT05860387 ·Status: RECRUITING
-
PCR for Aspergillus Fumigatus in Blood and Bronchoalveolar Lavage Fluid for Monitoring Cases of Invasive Aspergillosis: What is Its Prognostic Value
NCT07313527 ·Status: RECRUITING
-
Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients
NCT05720728 ·Status: COMPLETED
-
Performance Evaluation of the Fujifilm Wako Beta-D-glucan Technique in the Diagnosis of Major Invasive Fungal Infections (IFI)
NCT07272915 ·Status: COMPLETED
-
PCR Based Detection of Azole Resistance in A. Fumigatus to Improve Patient Outcome.
NCT03121235 ·Status: COMPLETED
-
Screening Anti-Fungal Exposure in Intensive Care Units
NCT03136926 ·Status: UNKNOWN
-
Fugal Infection in COVID-19 Patients
NCT04914013 ·Status: UNKNOWN
-
Diagnostic Performance of the CandID PLUS PCR for the Diagnosis of Intra-abdominal Candidiasis in Critically Ill Patients
NCT07005258 ·Status: COMPLETED
-
An Observational Study of Fungal Biomarkers (MK-0000-089)
NCT00854607 ·Status: COMPLETED
-
Validation of Pathologic Diagnosis of Invasive Fungal Infection by Molecular Method
NCT02676570 ·Status: UNKNOWN
-
A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)
NCT01174147 ·Status: COMPLETED
-
Evaluation of a Clinical Decision Support System for Fungal Infections
NCT05656157 ·Status: COMPLETED
-
Immunological Interaction Between the Host and Candida Albicans Biofilm
NCT01919931 ·Status: COMPLETED
-
Clinical Outcomes in Candidemia Patients Based on in Vitro Susceptibility
NCT01077336 ·Status: COMPLETED
-
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
NCT00462657 ·Status: UNKNOWN ·Phase: NA
-
Invasive Candidiasis in Critical Care
NCT06456151 ·Status: RECRUITING
-
Pharmacokinetics and Pharmacodynamics of Caspofungin (Cancidas ®) and Drug Tolerance of Fungi to Patients With an Invasive Fungal Infection in the Intensive Care Unit
NCT02510053 ·Status: UNKNOWN ·Phase: NA
-
Antigenic and Antibody Detection of Candida
NCT03766932 ·Status: UNKNOWN
-
fungalAi for Fungal Surveillance & Antifungal Stewardship
NCT03793231 ·Status: UNKNOWN
-
Exhaled Breath Analysis in the Early Detection of Aspergillosis
NCT02106117 ·Status: COMPLETED
-
Dosage of Plasma 1, 3-β-D-glucan for the Diagnosis of Candidemia.
NCT03674359 ·Status: UNKNOWN